Barkin, Jodie A.
Delk, Trudi B.
Powell, Valerie J.
Article History
Received: 30 June 2023
Accepted: 26 February 2024
First Online: 14 March 2024
Declarations
:
: Not applicable.
: Not applicable.
: JAB has received grants from the Cystic Fibrosis Foundation and consulting fees from Aimmune Therapeutics, CorEvitas, LLC, part of Thermo Fisher Scientific, AbbVie Inc, Envara Health, Exact Sciences, Organon, Motus GI, and Medtronic. VJP is an employee of CorEvitas, LLC, part of Thermo Fisher Scientific, which receives funding through Nestlé Health Science company for the design and execution of the exocrine pancreatic insufficiency registry. TBD is an employee of Aimmune Therapeutics, a Nestlé Health Science company.